CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
145 hedge funds and large institutions have $322M invested in Cymabay Therapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+25
Holders Change %
+20.83%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
46
Increased
41
Reduced
36
Closed
21
Calls
$1.9M
Puts
$3.98M
Net Calls
-$2.08M
Net Calls Change
-$4.62M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
$6.4M |
| 2 |
Goldman Sachs
New York
|
$5.4M |
| 3 |
Two Sigma Advisers
New York
|
$6.98M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$14.5M |
| 5 |
BlackRock
New York
|
$30.9M |
